We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $267M
1-Year Est. Return 965.83%
This Fund
S&P 500
This Quarter Est. Return
+0.19%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
–
AUM
$290M
AUM Growth
+$73.4M
Cap. Flow
+$107M
Cap. Flow %
36.9%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$107M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLAY icon
1
Relay Therapeutics
RLAY
$4.1B
$120M 41.22%
+2,811,197
New +$107M
DNTH icon
2
Dianthus Therapeutics
DNTH
$5.84B
$54.5M 18.75%
500,513
– –
RVMD icon
3
Revolution Medicines
RVMD
$39.9B
$49.4M 17.01%
1,419,900
– –
PLRX icon
4
Pliant Therapeutics
PLRX
$64.4M
$48.3M 16.63%
2,132,867
– –
FULC icon
5
Fulcrum Therapeutics
FULC
$273M
$18.6M 6.4%
2,343,154
– –

Similar funds

OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
WAM
Weinberger Asset Management Los Angeles, California $267M AUM 19.83% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SIA
SGL Investment Advisors Missoula, Montana $266M AUM 18.29% 1-Year Est. Return
CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
EU
Emory University Atlanta, Georgia $267M AUM 48.26% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return

TRV GP IV's Q3 2020 Portfolio in Review

As of Q3 2020, TRV GP IV held 5 positions worth $290M, up 34% from $217M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP IV deployed $107M of net new capital in Q3 2020, opening 1 new position. Its largest new stake was Relay Therapeutics: 2,811,197 shares worth $120M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV's largest Q3 2020 buy was Relay Therapeutics: 2,811,197 shares worth $120M.
  • TRV GP IV's ten largest holdings make up 100% of its $290M portfolio in Q3 2020.
  • TRV GP IV opened 1 new position and closed 0 in Q3 2020.
  • TRV GP IV's portfolio value rose 34% quarter-over-quarter to $290M.

Based on TRV GP IV's 13F filing for Q3 2020, filed 6 Nov 2020.